# generate_tests\Test mAB\IgG2-K-002.txt
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Trypsin - 50%
VTISVDTSK
GPSVFPLAPCSR
STSESTAALGCLVK
TPEVTCVVVDVSHEDPEVQFNWYVDGVEVHNAK
EPQVYTLPPSR
NQVSLTCLVK
GFYPSDIAVEWESNGQPENNYK
WQQGNVFSCSVMHEALHNHYTQK
SLSLSPGK
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Chymotrypsin - 50%
QESGPGL
VKPSQTL
IRQHPGKGL
KSRVTISVDTSKNQF
SSVTAADTAVY
APCSRSTSESTAAL
TSGVHTF
SSVVTVPSSNF
TCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVF
PPKPKDTL
ISRTPEVTCVVVDVSHEDPEVQF
TVVHQDW
KCKVSNKGL
PAPIEKTISKTKGQPREPQVY
PPSREEM
PSDIAVEW
KTTPPM
TVDKSRW
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - LysC - 50%
QVQLQESGPGLVK
PSQTLSLTCTVSGGSISSGEYYWNWIRQHPGK
NQFSLK
GPSVFPLAPCSRSTSESTAALGCLVK
GFYPSDIAVEWESNGQPENNYK
SRWQQGNVFSCSVMHEALHNHYTQK
SLSLSPGK
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Aspecific - 50%
LQESGPGLVKPSQTLSLTCTVSG
LVKPSQTLSLTCTVSGGSISSGEYYWNWIRQH
YYWNWIRQHPGKGLEWIGYIYY
NWIRQHPGK
GLEWIGYIYYS
LEWIGYIYYSGSTYY
STYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVY
NPSLKSRVTISVDTSKNQFS
ISVDTSKNQFSLKLSSVTAADTAVY
TSKNQFSLKLSSVTAADTAVYYCA
FSLKLSSVTAAD
DYWGQGT
YWGQGTLVTVSSAS
LVTVSSASTKGPSVFPLAPCSRSTSE
LVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFP
TKGPSVFPLAPCSRSTSESTAALGCLVKDYF
PSVFPLAP
STSESTAALGCLVKDYFPEPVTVSW
VKDYFPEPVTVSWNS
KDYFPEPVTV
TVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVP
WNSGALTSGVHTFPAVLQSSGLYSLSSV
FGTQTYTCN
GTQTYTCNVDHK
GTQTYTCNVDHKPSN
DHKPSNTKVDKT
DHKPSNTKVDKTVERKCCVEC
KVDKTVERKCCVECPPCPA
FLFPPKPKDTLMISRTPEVTCVVVDVSH
FLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFNW
FPPKPKDTLMISRTPEVTCVVVDVSH
ISRTPEVTC
VTCVVVDVSHEDPEVQFNWY
VTCVVVDVSHEDPEVQFNWYVDGVEVHNAKTKPREE
REEQFNSTF
EEQFNSTFRVV
EQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPI
RVVSVLTVVHQDWLNG
DWLNGKEYKCKVSNKGLPAPI
KEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLP
CKVSNKGLPAPIEKTI
VSNKGLPAPIEKTISKTK
PAPIEKTISKTKGQPREPQVYTLPPSRE
REPQVYTLPPSREE
CLVKGFYPSDIAVEWESNGQPENNYKTTPPML
PSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYS
IAVEWESNGQPENNYKTTPPMLDSDGS
FFLYSKLTVDKSR
LYSKLTVDKSRWQQGN
TVDKSRWQQGNVFSCSVMHEALHNHYTQKSL
SRWQQGNVFSCSVMHEALHNHYT
QGNVFSCSVMHEALHNHYTQKSLSLSPG
# Generated sample - 10106H|ascrinvacumab|Homo sapiens||H-GAMMA-2 (VH (1-118) [D1] + CH1 (119-216) [D2] + CH2 (229-337) [D3] + CH3 (338-442) [D4])|||||||444|444|||MW undefined|MW undefined| - Alfalytic protease - 50%
KDYFPEPV
ERKCCV
ECPPCPA
HEDPEV
QFNWYV
NKGLPA
KGQPREPQV
NGQPENNYKT
LHNHYT
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Trypsin - 50%
EIVLTQSPGTLSLSPGER
ASQSVSSSYLAWYQQKPGQAPR
LLIYGTSSR
LEPEDFAVYYCQQYGSSPITFGQGTR
TVAAPSVFIFPPSDEQLK
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Chymotrypsin - 50%
SPGERATL
GTSSRATGIPDRF
EIKRTVAAPSVF
KSGTASVVCL
PREAKVQW
QSGNSQESVTEQDSKDSTY
EKHKVY
ACEVTHQGL
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - LysC - 50%
SGTASVVCLLNNFYPREAK
DSTYSLSSTLTLSK
SFNRGEC
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Aspecific - 50%
SLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYG
TLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGTSSRATGI
QSVSSSYLAW
SSYLAWYQQKPGQAPRLLIYGTSSRATGIPDRFSGSGSGT
AWYQQKPGQAPRLLIYGTSS
YQQKPGQAPRLLIYGTSSRATGIPDRFSGSGSGTDFTLTI
PGQAPRLLIYGTSSRATGIPDRFSGSGSG
QAPRLLIYGTSSRATGIPDRFSG
PRLLIYGTSSRATGI
SGSGTDFTLTISRLEPEDFAVYYCQQYGSSPITFGQGT
GSGTDFTLTISRLEPEDFAVY
FTLTISRLEPEDFAVYYCQQYGSSPITFGQGTRLEIKRT
TLTISRLEPEDFAVYYC
RLEPEDFAVYYCQQYGS
EPEDFAVY
YCQQYGSS
ITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCL
FGQGTRLEI
GTRLEIKRTVAA
RLEIKRTVAAPSVFIFPPS
PPSDEQLKSGTASVVCLLNNFYP
KSGTASVVCLLNNFYP
LLNNFYPR
EAKVQWKVDNA
EAKVQWKVDNALQSGNSQESVTEQDSKDSTY
KVQWKVDNALQSGNSQESVTEQDS
ALQSGNSQESVTEQDSKDS
LQSGNSQESVTEQDSKDSTYS
TYSLSSTLTLSKADYEKHKVYACEVT
ACEVTHQGLSSPV
SSPVTKSFNRG
# Generated sample - 10106L|ascrinvacumab|Homo sapiens||L-KAPPA (V-KAPPA (1-108) [D1] + C-KAPPA (109-215) [D2])|||||||215|215|||MW undefined|MW undefined| - Alfalytic protease - 50%
WYQQKPGQA
GIPDRFS
YYCQQYGS
RLEIKRT
CLLNNFYPREA
FNRGEC
